Clark, Paul J <br/><br/>
Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Jul 2012 
 - 49-56 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.25631  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Albumins--therapeutic use<br/>Antiviral Agents--therapeutic use<br/>Cholesterol--genetics<br/>Chromatography, Gas<br/>Female<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Lanosterol--genetics<br/>Lipid Metabolism--drug effects<br/>Male<br/>Mass Spectrometry<br/>Middle Aged<br/>Oxidative Stress--genetics<br/>Pilot Projects<br/>Prognosis<br/>Ribavirin--therapeutic use<br/>Risk Assessment<br/>Severity of Illness Index<br/>Signal Transduction--genetics<br/>Statistics, Nonparametric<br/>Treatment Outcome